ABEO ABEONA THERAPEUTICS INC.companySEC Filings & Insider Trading Activity 2026
Latest ABEONA THERAPEUTICS INC. (ABEO) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 17, 2026, a 10-Q quarterly report filed on November 12, 2025, an 8-K current report filed on April 7, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for ABEONA THERAPEUTICS INC. (ABEO) (SEC CIK 318306), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q1 2025 earnings results disclosed via press release exhibit — refer to Exhibit 99.1 for actual financial figures
- • Filing structured to limit legal liability under Exchange Act Section 18 — standard earnings release protective language
Recent 8-K FilingsCurrent Reports
AI-powered analysis of ABEONA THERAPEUTICS INC. (ABEO) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 7, 2026 | — | — | — |
8-K | Mar 20, 2026 | — | — | — |
8-K | Mar 17, 2026 | — | Analysis | — |
10-K | Mar 17, 2026 | Dec 31, 2025 | — | |
8-K | Mar 9, 2026 | — | Analysis | — |
10-Q | Nov 12, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 14, 2025 | Jun 30, 2025 | — | |
10-Q | May 15, 2025 | Mar 31, 2025 | — | |
10-K | Mar 20, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 14, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 12, 2024 | Jun 30, 2024 | — | |
10-Q | May 15, 2024 | Mar 31, 2024 | — | |
10-K | Mar 18, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 13, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | — | |
10-Q | May 11, 2023 | Mar 31, 2023 | — | |
10-K | Mar 29, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 14, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 11, 2022 | Jun 30, 2022 | — | |
10-Q | May 13, 2022 | Mar 31, 2022 | — | |
10-K | Mar 31, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 15, 2021 | Sep 30, 2021 | — | |
10-Q | Jul 28, 2021 | Jun 30, 2021 | — | |
10-Q | May 17, 2021 | Mar 31, 2021 | — | |
10-K | Mar 24, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest ABEO SEC filings in 2026?
ABEONA THERAPEUTICS INC. (ABEO) has filed a 10-K annual report on March 17, 2026, a 10-Q quarterly report on November 12, 2025, an 8-K current report on April 7, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ABEO file its most recent 10-K annual report?
ABEONA THERAPEUTICS INC. (ABEO) filed its most recent 10-K annual report on March 17, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ABEO 10-Q quarterly reports?
ABEONA THERAPEUTICS INC. (ABEO)'s most recent 10-Q quarterly report was filed on November 12, 2025. SignalX displays every ABEO 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ABEO filed recently?
ABEONA THERAPEUTICS INC. (ABEO)'s most recent 8-K was filed on April 7, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ABEO insider trading activity (Form 4)?
SignalX aggregates every ABEO Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ABEO file with the SEC?
ABEONA THERAPEUTICS INC. (ABEO) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ABEO filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for ABEONA THERAPEUTICS INC. (ABEO).
What is ABEO's SEC CIK number?
ABEONA THERAPEUTICS INC. (ABEO)'s SEC CIK (Central Index Key) number is 318306. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 318306 to look up all ABEO filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ABEO return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from ABEONA THERAPEUTICS INC. (ABEO) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of ABEONA THERAPEUTICS INC. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 77+ filings.